Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Matei, Daniela, Filiaci, Virginia, Randall, Marcus E, Mutch, David, Steinhoff, Margaret M, DiSilvestro, Paul A, Moxley, Katherine M, Kim, Yong M, Powell, Matthew A, O’Malley, David M, Spirtos, Nick M, Small, William, Tewari, Krishnansu S, Richards, William E, Nakayama, John, Matulonis, Ursula A, Huang, Helen Q, Miller, David S
Published in The New England journal of medicine (13.06.2019)
Published in The New England journal of medicine (13.06.2019)
Get full text
Journal Article
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Moore, Kathleen N, Martin, Lainie P, O'Malley, David M, Matulonis, Ursula A, Konner, Jason A, Perez, Raymond P, Bauer, Todd M, Ruiz-Soto, Rodrigo, Birrer, Michael J
Published in Journal of clinical oncology (01.04.2017)
Published in Journal of clinical oncology (01.04.2017)
Get full text
Journal Article
PARP Inhibitors in Ovarian Cancer: A Review
O’Malley, David M., Krivak, Thomas C., Kabil, Nashwa, Munley, Jiefen, Moore, Kathleen N.
Published in Targeted oncology (01.07.2023)
Published in Targeted oncology (01.07.2023)
Get full text
Journal Article
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Fader, Amanda N, Roque, Dana M, Siegel, Eric, Buza, Natalia, Hui, Pei, Abdelghany, Osama, Chambers, Setsuko K, Secord, Angeles Alvarez, Havrilesky, Laura, O'Malley, David M, Backes, Floor, Nevadunsky, Nicole, Edraki, Babak, Pikaart, Dirk, Lowery, William, ElSahwi, Karim S, Celano, Paul, Bellone, Stefania, Azodi, Masoud, Litkouhi, Babak, Ratner, Elena, Silasi, Dan-Arin, Schwartz, Peter E, Santin, Alessandro D
Published in Journal of clinical oncology (10.07.2018)
Published in Journal of clinical oncology (10.07.2018)
Get full text
Journal Article
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study
Oaknin, Ana, Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O’Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda, Ghamande, Sharad, Ghatage, Prafull, Kristeleit, Rebecca, Leath III, Charles, Guo, Wei, Im, Ellie, Zildjian, Sybil, Han, Xinwei, Duan, Tao, Veneris, Jennifer, Pothuri, Bhavana
Published in Journal for immunotherapy of cancer (01.01.2022)
Published in Journal for immunotherapy of cancer (01.01.2022)
Get full text
Journal Article
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45)
Monk, Bradley J, Parkinson, Christine, Lim, Myong Cheol, O'Malley, David M, Oaknin, Ana, Wilson, Michelle K, Coleman, Robert L, Lorusso, Domenica, Bessette, Paul, Ghamande, Sharad, Christopoulou, Athina, Provencher, Diane, Prendergast, Emily, Demirkiran, Fuat, Mikheeva, Olga, Yeku, Oladapo, Chudecka-Glaz, Anita, Schenker, Michael, Littell, Ramey D, Safra, Tamar, Chou, Hung-Hsueh, Morgan, Mark A, Drochýtek, Vít, Barlin, Joyce N, Van Gorp, Toon, Ueland, Fred, Lindahl, Gabriel, Anderson, Charles, Collins, Dearbhaile C, Moore, Kathleen, Marme, Frederik, Westin, Shannon N, McNeish, Iain A, Shih, Danny, Lin, Kevin K, Goble, Sandra, Hume, Stephanie, Fujiwara, Keiichi, Kristeleit, Rebecca S
Published in Journal of clinical oncology (01.12.2022)
Published in Journal of clinical oncology (01.12.2022)
Get full text
Journal Article
Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Coleman, Robert L, Prof, Brady, Mark F, Prof, Herzog, Thomas J, Prof, Sabbatini, Paul, Prof, Armstrong, Deborah K, Prof, Walker, Joan L, Prof, Kim, Byoung-Gie, Prof, Fujiwara, Keiichi, Prof, Tewari, Krishnansu S, Prof, O'Malley, David M, Prof, Davidson, Susan A, MD, Rubin, Stephen C, Prof, DiSilvestro, Paul, Prof, Basen-Engquist, Karen, Prof, Huang, Helen, MS, Chan, John K, MD, Spirtos, Nick M, MD, Ashfaq, Raheela, MD, Mannel, Robert S, MD
Published in The lancet oncology (01.06.2017)
Published in The lancet oncology (01.06.2017)
Get full text
Journal Article
Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study
Hensley, Martee L, Enserro, Danielle, Hatcher, Helen, Ottevanger, Petronella B, Krarup-Hansen, Anders, Blay, Jean-Yves, Fisher, Cyril, Moxley, Katherine M, Lele, Shashikant B, Lea, Jayanthi S, Tewari, Krishnansu S, Thaker, Premal H, Zivanovic, Oliver, O'Malley, David M, Robison, Katina, Miller, David S
Published in Journal of clinical oncology (20.11.2018)
Published in Journal of clinical oncology (20.11.2018)
Get full text
Journal Article
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum
Monk, Bradley J, Grisham, Rachel N, Banerjee, Susana, Kalbacher, Elsa, Mirza, Mansoor Raza, Romero, Ignacio, Vuylsteke, Peter, Coleman, Robert L, Hilpert, Felix, Oza, Amit M, Westermann, Anneke, Oehler, Martin K, Pignata, Sandro, Aghajanian, Carol, Colombo, Nicoletta, Drill, Esther, Cibula, David, Moore, Kathleen N, Christy-Bittel, Janna, Del Campo, Josep M, Berger, Regina, Marth, Christian, Sehouli, Jalid, O'Malley, David M, Churruca, Cristina, Boyd, Adam P, Kristensen, Gunnar, Clamp, Andrew, Ray-Coquard, Isabelle, Vergote, Ignace
Published in Journal of clinical oncology (10.11.2020)
Published in Journal of clinical oncology (10.11.2020)
Get full text
Journal Article
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer
Meyer, Larissa A, Cronin, Angel M, Sun, Charlotte C, Bixel, Kristin, Bookman, Michael A, Cristea, Mihaela C, Griggs, Jennifer J, Levenback, Charles F, Burger, Robert A, Mantia-Smaldone, Gina, Matulonis, Ursula A, Niland, Joyce C, O'Malley, David M, Wright, Alexi A
Published in Journal of clinical oncology (10.11.2016)
Published in Journal of clinical oncology (10.11.2016)
Get full text
Journal Article
A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
Aghajanian, Carol, Filiaci, Virginia, Dizon, Don S., Carlson, Jay W., Powell, Matthew A., Secord, Angeles Alvarez, Tewari, Krishnansu S., Bender, David P., O'Malley, David M., Stuckey, Ashley, Gao, JianJiong, Dao, Fanny, Soslow, Robert A., Lankes, Heather A., Moore, Kathleen, Levine, Douglas A.
Published in Gynecologic oncology (01.08.2018)
Published in Gynecologic oncology (01.08.2018)
Get full text
Journal Article
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Kondrashova, Olga, Nguyen, Minh, Shield-Artin, Kristy, Tinker, Anna V, Teng, Nelson N H, Harrell, Maria I, Kuiper, Michael J, Ho, Gwo-Yaw, Barker, Holly, Jasin, Maria, Prakash, Rohit, Kass, Elizabeth M, Sullivan, Meghan R, Brunette, Gregory J, Bernstein, Kara A, Coleman, Robert L, Floquet, Anne, Friedlander, Michael, Kichenadasse, Ganessan, O'Malley, David M, Oza, Amit, Sun, James, Robillard, Liliane, Maloney, Lara, Bowtell, David, Giordano, Heidi, Wakefield, Matthew J, Kaufmann, Scott H, Simmons, Andrew D, Harding, Thomas C, Raponi, Mitch, McNeish, Iain A, Swisher, Elizabeth M, Lin, Kevin K, Scott, Clare L
Published in Cancer discovery (01.09.2017)
Published in Cancer discovery (01.09.2017)
Get full text
Journal Article
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Lin, Kevin K, Harrell, Maria I, Oza, Amit M, Oaknin, Ana, Ray-Coquard, Isabelle, Tinker, Anna V, Helman, Elena, Radke, Marc R, Say, Carmen, Vo, Lan-Thanh, Mann, Elaina, Isaacson, Jeffrey D, Maloney, Lara, O'Malley, David M, Chambers, Setsuko K, Kaufmann, Scott H, Scott, Clare L, Konecny, Gottfried E, Coleman, Robert L, Sun, James X, Giordano, Heidi, Brenton, James D, Harding, Thomas C, McNeish, Iain A, Swisher, Elizabeth M
Published in Cancer discovery (01.02.2019)
Published in Cancer discovery (01.02.2019)
Get full text
Journal Article
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial
Ledermann, Jonathan A, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew R, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O'Malley, David M, Armstrong, Deborah K, Banerjee, Susana, García-Donas, Jesus, Swisher, Elizabeth M, Cameron, Terri, Maloney, Lara, Goble, Sandra, Coleman, Robert L
Published in The lancet oncology (01.05.2020)
Published in The lancet oncology (01.05.2020)
Get full text
Journal Article
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer
Monk, Bradley J, Coleman, Robert L, Fujiwara, Keiichi, Wilson, Michelle K, Oza, Amit M, Oaknin, Ana, O’Malley, David M, Lorusso, Domenica, Westin, Shannon N, Safra, Tamar, Herzog, Thomas J, Marmé, Frederik, N Eskander, Ramez, Lin, Kevin K, Shih, Danny, Goble, Sandra, Grechko, Nikolay, Hume, Stephanie, Maloney, Lara, McNeish, Iain A, Kristeleit, Rebecca S
Published in International journal of gynecological cancer (01.12.2021)
Published in International journal of gynecological cancer (01.12.2021)
Get full text
Journal Article
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial
Mirza, Mansoor R., González‐Martín, Antonio, Graybill, Whitney S., O’Malley, David M., Gaba, Lydia, Stephanie Yap, Oi Wah, Guerra, Eva M., Rose, Peter G., Baurain, Jean‐François, Ghamande, Sharad A., Denys, Hannelore, Prendergast, Emily, Pisano, Carmela, Follana, Philippe, Baumann, Klaus, Calvert, Paula M., Korach, Jacob, Li, Yong, Malinowska, Izabela A., Gupta, Divya, Monk, Bradley J.
Published in Cancer (15.06.2023)
Published in Cancer (15.06.2023)
Get full text
Journal Article